← Open Payments lookup

FELICITAS MAVUNGA: Open Payments

NPI 1871957340 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$542 in 26 payments from 13 companies in 2025. Trend: 2023 $250 · 2024 $206 · 2025 $542

Food & beverage: $542
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$68
Lundbeck LLC3$62
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$61
Alkermes, Inc.3$61
Axsome Therapeutics, Inc.3$56
Takeda Pharmaceuticals U.S.A., Inc.3$50
Collegium Pharmaceutical, Inc.2$42
Noven Therapeutics, LLC2$37
Corium, LLC1$26
Vanda Pharmaceuticals Inc.1$21

Products named: REXULTI, CAPLYTA, ARISTADA, Auvelity, TRINTELLIX, Jornay PM, Xelstrym, ABILIFY ASIMTUFII.

Industry payments across NE — which companies pay providers there.